S 2103
116th Congress
Senate
Health
Digestive and metabolic diseases
Drug safety, medical device, and laboratory regulation
Drug therapy
Licensing and registrations
Prescription drugs
Affordable Insulin Approvals Now Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 11, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
Jul 11, 2019
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Affordable Insulin Approvals Now Act
This bill requires the continued review and approval, as appropriate, of certain pending applications for generic insulin beyond the March 23, 2020, cutoff date previously established by the Food and Drug Administration. Beginning March 23, 2020, these approved generic insulin drugs also are deemed licensed biological products.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
Related & companion bills
1
Bill text
1 version
- Introduced in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Cite this page
U.S. Congress. (2026). S. 2103: Affordable Insulin Approvals Now Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-2103/
"S. 2103: Affordable Insulin Approvals Now Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-2103/.
S. 2103, 116th Cong. (2026), https://openamerica.io/bill/116-S-2103/.
[S. 2103: Affordable Insulin Approvals Now Act](https://openamerica.io/bill/116-S-2103/)